EPFL researchers have developed a type of peptides that can enter cells and block protein interactions considered difficult to target with drugs.

Many diseases are driven by proteins interacting with each other inside cells. But blocking these interactions with drugs is difficult because typical "small-molecule" drugs often…

EPFL researchers have developed a type of peptides that can enter cells and block protein interactions considered difficult to target with drugs.